✦ LIBER ✦

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

✍ Scribed by Gitelman, Stephen E; Gottlieb, Peter A; Rigby, Mark R; Felner, Eric I; Willi, Steven M; Fisher, Lynda K; Moran, Antoinette; Gottschalk, Michael; Moore, Wayne V; Pinckney, Ashley; Keyes-Elstein, Lynette; Aggarwal, Sudeepta; Phippard, Deborah; Sayre, Peter H; Ding, Linna; Bluestone, Jeffrey A; Ehlers, Mario R

Book ID: 121972949
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 737 KB
Volume: 1
Category: Article
ISSN: 2213-8587
DOI: 10.1016/S2213-8587(13)70065-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with sitagliptin and

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

✍ Griffin, Kurt J; Thompson, Paul A; Gottschalk, Michael; Kyllo, Jennifer H; Rabin 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 388 KB

Targeting of memory T cells with aleface

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

✍ Rigby, Mark R; DiMeglio, Linda A; Rendell, Marc S; Felner, Eric I; Dostou, Jean 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 569 KB

Long term treatment with metformin in pa

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

✍ Jolien de Jager, Adriaan Kooy, Philippe Lehert, Michiel G Wulffelé, Jan van der 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 300 KB

Boceprevir versus placebo with pegylated

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

✍ Sulkowski, Mark; Pol, Stanislas; Mallolas, Josep; Fainboim, Hugo; Cooper, Curtis 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 333 KB

Safety Profile and Metabolic Effects of

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

✍ Sherwyn L. Schwartz; Marc Rendell; Andrew J. Ahmann; Asha Thomas; Carlos J. Arau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 118 KB